4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-033994
Director sold 600,000 shares at $8.45 ($5,070,000)
From the SEC's structured data for this filing
Trades in this filing
Hallal David · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-10-19 | Sale : show line 1 in the form | −600,000 | $8.45 | $5,070,000 | 138,153 | I |
| Open-market sales · 600,000 sh · avg $8.45 · $5,070,000 | ||||||
Loading xslF345X03/doc4.xml…